M1 protein from streptococcus pyogenes induces nitric oxide-mediated vascular hyporesponsiveness to phenylephrine: Involvement of toll-like receptor activation

Shock

Volumn 34, Issue 1, 2010, Pages 98-104

  Sigurdardottir, Thorgerdur ^a   Björck, Viveka ^a   Herwald, Heiko ^b   Mörgelin, Matthias ^b   Rutardottir, Sigurbjörg ^b   Törnebrant, Johan ^a   Bodelsson, Mikael ^a  

^a Divisions of Anesthesiology and Intensive Care   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Adrenoceptor; circulation; knockout mice; sepsis; serotype; shock; TLR; vasopressor

Indexed keywords

BACTERIAL PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHENYLEPHRINE; PROTEIN M1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; IMMUNOGOLD ELECTRON MICROSCOPY; IN VITRO STUDY; INCUBATION TEMPERATURE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRESSOR RESPONSE; PROTEIN BINDING; RAT; SMOOTH MUSCLE CONTRACTION; STREPTOCOCCUS PYOGENES; VASOCONSTRICTION; WILD TYPE;

ANIMALS; ANTIGENS, BACTERIAL; AORTA; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOCOCCUS PYOGENES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 77953879303     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181cdc50f     Document Type: Article

References (41)

1. Lancefield RC: Current knowledge of type-specific M antigens of group A streptococci. J Immunol 89:307-313, 1962.
2. Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE: Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547-554, 1996.
3. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, et al.: An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 8:1398-1404, 2002.
4. Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13:470-511, 2000.
5. Smoot JC, Korgenski EK, Daly JA, Veasy LG, Musser JM: Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 40:1805-1810, 2002.
6. McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet V, Ghosh P: Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science 319:1405-1408, 2008.
7. Li Z, Sakota V, Jackson D, Franklin AR, Beall B: Array of M protein gene subtypes in 1064 recent invasive group A Streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis 188:1587-1592, 2003.
8. Talkington DF, Schwartz B, Black CM, Todd JK, Elliott J, Breiman RF, Facklam RR: Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of strepto-coccal toxic shock syndrome. Infect Immun 61:3369-3374, 1993.
9. Bochud PY, Calandra T: Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326:262-266, 2003.
10. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284-288, 1998.
11. Opal SM, Huber CE: Bench-to-bedside review: Toll-like receptors and their role in septic shock. Crit Care 6:125-136, 2002.
12. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Cutting edge: Toll-like receptor 4 (TLR4)Ydeficient mice are hypo-responsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162:3749-3752, 1999.
13. Mitchell JA, Paul-Clark MJ, Clarke GW, McMaster SK, Cartwright N: Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J Endocrinol 193:323-330, 2007.
14. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S: Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451, 1999.
15. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376, 1980.
16. Kirkeboen KA, Strand OA: The role of nitric oxide in sepsisYan overview. Acta Anaesthesiol Scand 43:275-288, 1999.
17. Fernandes D, Assreuy J: Nitric oxide and vascular reactivity in sepsis. Shock 30(suppl 1):10-13, 2008.
18. Pa°hlman LI, Mörgelin M, Eckert J, Johansson L, Russell W, Riesbeck K, Soehnlein O, Lindbom L, Norrby-Teglund A, Schumann RR, et al.: Strep-tococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 177:1221-1228, 2006.
19. Pa°hlman LI, Olin AI, Darenberg J, Mörgelin M, Kotb M, Herwald H, Norrby-Teglund A: Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 10:404-414, 2008.
20. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M: Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation. J Immunol 166:2018-2024, 2001.
21. Collin M, Olsen A: Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 36:1306-1318, 2000.
22. Baschong W, Wrigley NG: Small colloidal gold conjugated to Fab fragments or to immunoglobulin G as high-resolution labels for electron microscopy: a technical overview. J Electron Microsc Tech 14:313-323, 1990.
23. Roth J: Post-embedding cytochemistry with gold-labelled reagents: a review. J Microsc 143:125-137, 1986.
24. Cartwright N, McMaster SK, Sorrentino R, Paul-Clark M, Sriskandan S, Ryffel B, Quesniaux VF, Evans TW, Mitchell JA: Elucidation of toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive Staphylococcus aureus or gram-negative Escherichia coli. Shock 27:40-47, 2007.
25. Beasley D, Cohen RA, Levinsky NG: Endotoxin inhibits contraction of vascular smooth muscle in vitro. Am J Physiol 258:H1187-H1192, 1990.
26. Ciornei CD, Egesten A, Engström M, Törnebrandt K, Bodelsson M: Bactericidal/permeability-increasing protein inhibits endotoxin-induced vascular nitric oxide synthesis. Acta Anaesthesiol Scand 46:1111-1118, 2002.
27. Ciornei CD, Egesten A, Bodelsson M: Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Acta Anaesthesiol Scand 47:213-220, 2003.
28. Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet JC: Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 171:562-568, 1990. (Pubitemid 20289421)
29. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259:H1038YH1043, 1990.
30. Terluk M, Cunha Da Silva E, Antunes T, Assreuy J: The presence of the endothelial layer reduces nitric oxideYinduced hyporesponsiveness to phenyl-ephrine in rat aorta. Endothelium 11:181-187, 2004.
31. Aikawa J, Akatsuka N: Vascular smooth muscle relaxation by endothelium-dependent beta 1Yadrenergic action. Comp Biochem Physiol C Toxicol Pharmacol 97:311-315, 1990.
32. Heesen BJ, Hotchkiss RS, Karl IE: Sepsis decreases phenylephrine-and KCl-induced aortic ring contraction and decreases the frequency of oscillations in active wall tension. Shock 2:106-112, 1994.
33. Matsumura M, Kakishita H, Suzuki M, Banba N, Hattori Y: Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci 69:1067-1077, 2001.
34. Fukazawa H, Noguchi K, Murakami Y, Uehara Y: Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. Mol Cancer Ther 1:303-309, 2002.
35. Liu XH, Zhang ZY, Sun S, Wu XD: Ischemic postconditioning protects myocardium from ischemia/reperfusion injury through attenuating endoplasmic reticulum stress. Shock 30:422-427, 2008.
36. Nwariaku FE, Chang J, Zhu X, Liu Z, Duffy SL, Halaihel NH, Terada L, Turnage RH: The role of p38 map kinase in tumor necrosis factorYinduced redistribution of vascular endothelial cadherin and increased endothelial permeability. Shock 18:82-85, 2002.
37. Gharavi NM, Alva JA, Mouillesseaux KP, Lai C, Yeh M, Yeung W, Johnson J, Szeto WL, Hong L, Fishbein M, et al.: Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J Biol Chem 282:31460-31468, 2007.
38. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y: Cortico-steroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329:480, 2004.
39. Seeling M, Eggers V, Spies C: Surviving sepsis campaign: guideline clarification. Crit Care Med 36:2490, 2008 [author reply 2490-2491].
40. Rehli M: Of mice and men: species variations of Toll-like receptor expression. Trends Immunol 23:375-378, 2002.
41. Eriksson BK, Andersson J, Holm SE, Norgren M: Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 27:1428-1436, 1998.